Frits C. Stevens

2.0k total citations
32 papers, 1.5k citations indexed

About

Frits C. Stevens is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Frits C. Stevens has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Physiology. Recurrent topics in Frits C. Stevens's work include Phosphodiesterase function and regulation (8 papers), Insect Resistance and Genetics (7 papers) and Biochemical and Structural Characterization (6 papers). Frits C. Stevens is often cited by papers focused on Phosphodiesterase function and regulation (8 papers), Insect Resistance and Genetics (7 papers) and Biochemical and Structural Characterization (6 papers). Frits C. Stevens collaborates with scholars based in Canada, United States and Sweden. Frits C. Stevens's co-authors include Michael P. Walsh, John Krahn, Robert E. Feeney, David M. Waisman, Cyril M. Kay, Hsing-Ying Ho, Emil L. Smith, Jacek Kuźnicki, W. Drabikowski and Kim Oikawa and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Frits C. Stevens

32 papers receiving 1.3k citations

Peers

Frits C. Stevens

CMN

David B. Millar United States

Yukio Sugino Japan

Anthony Lévy United States

Allen M. Gold United States

Gianfranco Borin Italy

Julius A. Gordon United States

Hans Ulrich Schairer Germany

J.F. Cutfield New Zealand

Albert Light United States

Roger W. Roeske United States

David B. Millar United States

Frits C. Stevens

844 ×0.8

142 ×0.7

167 ×1.1

124 ×1.0

113 ×1.0

CMN

Citations per year, relative to Frits C. Stevens Frits C. Stevens (= 1×) peers David B. Millar

Countries citing papers authored by Frits C. Stevens

Since Specialization

Citations

This map shows the geographic impact of Frits C. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frits C. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frits C. Stevens more than expected).

Fields of papers citing papers by Frits C. Stevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frits C. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frits C. Stevens. The network helps show where Frits C. Stevens may publish in the future.

Co-authorship network of co-authors of Frits C. Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Frits C. Stevens. A scholar is included among the top collaborators of Frits C. Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frits C. Stevens. Frits C. Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stevens, Frits C., Marlene L. Cohen, Mark L. Heiman, et al.. (2007). Potent oxindole based human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(22). 6270–6273. 43 indexed citations

Jesudason, Cynthia D., Lisa S. Beavers, Jeffrey W. Cramer, et al.. (2006). Synthesis and SAR of novel histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(13). 3415–3418. 32 indexed citations

Larsen, Scott D., Frits C. Stevens, Theresa J. O’Sullivan, et al.. (2003). Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activity. Bioorganic & Medicinal Chemistry Letters. 13(5). 971–975. 23 indexed citations

Vaillancourt, Valerie, Scott D. Larsen, Steven P. Tanis, et al.. (2001). Synthesis and Biological Activity of Aminoguanidine and Diaminoguanidine Analogues of the Antidiabetic/Antiobesity Agent 3-Guanidinopropionic Acid. Journal of Medicinal Chemistry. 44(8). 1231–1248. 42 indexed citations

Larsen, Scott D., Mark A. Connell, Paul D. May, et al.. (2001). Synthesis and Biological Activity of Analogues of the Antidiabetic/Antiobesity Agent 3-Guanidinopropionic Acid: Discovery of a Novel Aminoguanidinoacetic Acid Antidiabetic Agent. Journal of Medicinal Chemistry. 44(8). 1217–1230. 53 indexed citations

Larsen, Scott D., Tjeerd Barf, Charlotta Liljebris, et al.. (2001). Synthesis and Biological Activity of a Novel Class of Small Molecular Weight Peptidomimetic Competitive Inhibitors of Protein Tyrosine Phosphatase 1B. Journal of Medicinal Chemistry. 45(3). 598–622. 60 indexed citations

Blanchaer, M. C. & Frits C. Stevens. (1984). Programming a clinical case simulation on a microcomputer. Biochemical Education. 12(1). 29–33. 5 indexed citations

Waisman, David M., et al.. (1978). Purification and characterization of a Ca2+-binding protein in Lumbricus terrestris. Journal of Biological Chemistry. 253(4). 1106–1113. 53 indexed citations

Walsh, Michael P., Frits C. Stevens, Jacek Kuźnicki, & W. Drabikowski. (1977). Characterization of tryptic fragments obtained from bovine brain protein modulator of cyclic nucleotide phosphodiesterase.. Journal of Biological Chemistry. 252(21). 7440–7443. 121 indexed citations

10.

Stevens, Frits C., et al.. (1973). Lima Bean Protease Inhibitor: Reduction and Reoxidation of the Disulfide Bonds and Their Reactivity in the Trypsin–inhibitor Complex. Canadian Journal of Biochemistry. 51(7). 1021–1028. 5 indexed citations

11.

Krahn, John & Frits C. Stevens. (1972). Lima bean protease inhibitor: Comparative study of the trypsin and chymotrypsin inhibitory activities of four chromatographically pure variants. FEBS Letters. 28(3). 313–316. 3 indexed citations

12.

Krahn, John & Frits C. Stevens. (1971). Stoichiometry of the interaction of lima bean protease inhibitor with trypsin and/or chymotrypsin. FEBS Letters. 13(6). 339–341. 17 indexed citations

13.

Stevens, Frits C., et al.. (1971). Amino Acid Sequence of Lima Bean Protease Inhibitor Component IV. European Journal of Biochemistry. 18(4). 503–514. 26 indexed citations

14.

Stevens, Frits C., et al.. (1971). Amino Acid Sequence of Lima Bean Protease Inhibitor Component IV. European Journal of Biochemistry. 18(4). 515–523. 51 indexed citations

15.

Stevens, Frits C., Douglas M. Brown, & Emil L. Smith. (1970). Some properties of soybean lipoxygenase. Archives of Biochemistry and Biophysics. 136(2). 413–421. 55 indexed citations

16.

Krahn, John & Frits C. Stevens. (1970). Lima bean trypsin inhibitor. Limited proteolysis by trypsin and chymotrypsin. Biochemistry. 9(13). 2646–2652. 53 indexed citations

17.

Stevens, Frits C., Alexander N. Glazer, & Emil L. Smith. (1967). The Amino Acid Sequence of Wheat Germ Cytochrome c. Journal of Biological Chemistry. 242(11). 2764–2779. 47 indexed citations

18.

Stevens, Frits C., et al.. (1966). Reduction and reoxidatoin of ovomucoids. Biochimica et Biophysica Acta (BBA) - General Subjects. 130(2). 549–551. 5 indexed citations

19.

Feeney, Robert E., Frits C. Stevens, & David T. Osuga. (1963). The Specificities of Chicken Ovomucoid and Ovoinhibitor. Journal of Biological Chemistry. 238(4). 1415–1418. 76 indexed citations

20.

Stevens, Frits C. & Robert E. Feeney. (1963). Chemical Modification of Avian Ovomucoids^*. Biochemistry. 2(6). 1346–1352. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact